MEREDITH RIVENBARK: Open Payments
NPI 1679190284 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,466 in 79 payments from 12 companies in 2025. Trend: 2023 $685 · 2024 $1,385 · 2025 $1,466
Food & beverage: $1,466
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $348 |
| ABBVIE INC. | 32 | $341 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $175 |
| Madrigal Pharmaceuticals | 6 | $121 |
| QOL Medical, LLC | 3 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Aimmune Therapeutics, Inc. | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Ardelyx, Inc. | 2 | $45 |
Products named: DUPIXENT, REZDIFFRA, CREON, Sucraid, ENTYVIO, RINVOQ, ZENPEP, EOHILIA.
Industry payments across SC — which companies pay providers there.
